Literature DB >> 27634202

Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia.

Paolo Strati1, Kari G Chaffee1, Sara J Achenbach1, Susan L Slager1, Nelson Leung1, Timothy G Call1, Wei Ding1, Sameer A Parikh1, Neil E Kay1, Tait D Shanafelt2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27634202      PMCID： PMC5210254          DOI： 10.3324/haematol.2016.150706

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia.

Authors:  Paul Thurmes; Timothy Call; Susan Slager; Clive Zent; Gregory Jenkins; Susan Schwager; Deborah Bowen; Neil Kay; Tait Shanafelt
Journal:  Leuk Lymphoma       Date:  2008-01

Review 2.  Early recognition and prevention of chronic kidney disease.

Authors:  Matthew T James; Brenda R Hemmelgarn; Marcello Tonelli
Journal:  Lancet       Date:  2010-04-10       Impact factor: 79.321

3.  Chronic lymphocytic leukemia: planning for an aging population.

Authors:  John G Gribben
Journal:  Expert Rev Anticancer Ther       Date:  2010-09       Impact factor: 4.512

4.  Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.

Authors:  Timothy G Call; Aaron D Norman; Curtis A Hanson; Sara J Achenbach; Neil E Kay; Clive S Zent; Wei Ding; James R Cerhan; Kari G Rabe; Celine M Vachon; Emily J Hallberg; Tait D Shanafelt; Susan L Slager
Journal:  Cancer       Date:  2014-04-07       Impact factor: 6.860

5.  Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience.

Authors:  Paolo Strati; Samih H Nasr; Nelson Leung; Curtis A Hanson; Kari G Chaffee; Susan M Schwager; Sara J Achenbach; Timothy G Call; Sameer A Parikh; Wei Ding; Neil E Kay; Tait D Shanafelt
Journal:  Haematologica       Date:  2015-06-18       Impact factor: 9.941

6.  Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials.

Authors:  Valentin Goede; Paula Cramer; Raymonde Busch; Manuela Bergmann; Martina Stauch; Georg Hopfinger; Stephan Stilgenbauer; Hartmut Döhner; Anne Westermann; Clemens M Wendtner; Barbara Eichhorst; Michael Hallek
Journal:  Haematologica       Date:  2014-02-28       Impact factor: 9.941

Review 7.  Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG).

Authors:  Paula Cramer; Petra Langerbeins; Barbara Eichhorst; Michael Hallek
Journal:  Eur J Haematol       Date:  2015-11-06       Impact factor: 2.997

Review 8.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Authors:  Ron T Gansevoort; Ricardo Correa-Rotter; Brenda R Hemmelgarn; Tazeen H Jafar; Hiddo J Lambers Heerspink; Johannes F Mann; Kunihiro Matsushita; Chi Pang Wen
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

Review 9.  IMWG consensus on risk stratification in multiple myeloma.

Authors:  W J Chng; A Dispenzieri; C-S Chim; R Fonseca; H Goldschmidt; S Lentzsch; N Munshi; A Palumbo; J S Miguel; P Sonneveld; M Cavo; S Usmani; B G M Durie; H Avet-Loiseau
Journal:  Leukemia       Date:  2013-08-26       Impact factor: 11.528
  9 in total
  4 in total

1.  Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

Authors:  Paul J Hampel; Kari G Chaffee; Rebecca L King; Douglas Simonetto; Melissa C Larson; Sara Achenbach; Timothy G Call; Wei Ding; Saad S Kenderian; Jose F Leis; Asher A Chanan-Khan; Deborah A Bowen; Michael J Conte; Susan M Schwager; Curtis A Hanson; Susan L Slager; Neil E Kay; Tait D Shanafelt; Sameer A Parikh
Journal:  Am J Hematol       Date:  2017-10-19       Impact factor: 10.047

2.  Risk factors for renal impairment in patients with hematological cancer receiving antineoplastic treatment.

Authors:  Priscila Nunes Costa Travassos; Paulo Goberlânio de Barros Silva; Milena Oliveira Freitas; Marcus Davis Machado Braga; Fernando Barroso Duarte; Jéssica Karen de Oliveira Maia; Helena Pitombeira; Jacqueline Holanda de Sousa; Ana Paula Negreiros Nunes Alves
Journal:  Support Care Cancer       Date:  2022-05-21       Impact factor: 3.359

Review 3.  Dysproteinemias and Glomerular Disease.

Authors:  Nelson Leung; Maria E Drosou; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-07       Impact factor: 8.237

4.  Renal Dysfunction in Patients With Direct Infiltration by B-Cell Lymphoma.

Authors:  Lea Corlu; Nathalie Rioux-Leclercq; Michel Ganard; Olivier Decaux; Roch Houot; Cécile Vigneau
Journal:  Kidney Int Rep       Date:  2019-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.